Taspoglutide, a Once-Weekly Human GLP-1 Analog, Reduces Body Weight, Waist and Hip Circumferences, and Decreases Appetite in Obese Patients With Type 2 Diabetes (T2D): Results From the Phase 3T-Emerge 7Trial
- Resource Type
- Journal
- Source
OBESITY ; OCT 2010, 18 pS155-pS155, 1p. Supplement: 2- Subject
- Language
- English
- ISSN
- 19307381